Although it is clear that SOX9 expression can be regulated at the transcriptional level, our data indicate that the posttranslational modulation of SOX9 stability through KEAP1‐mediated proteasome degradation represents another essential mechanism that contributes to SOX9 regulation in human lung carcinoma and HCC. This evidence concerns the gene KEAP1 and hepatocellular carcinoma.